Index S&P 500
P/E 23.47
EPS (ttm) 4.62
Insider Own 0.13%
Shs Outstand 205.60M
Perf Week 2.03%
Market Cap 22.30B
Forward P/E 12.46
EPS next Y 8.70
Insider Trans -13.21%
Shs Float 205.47M
Perf Month -6.81%
Income 963.90M
PEG 3.40
EPS next Q 1.99
Inst Own 92.07%
Short Float 2.25%
Perf Quarter -18.25%
Sales 7.45B
P/S 2.99
EPS this Y 7.25%
Inst Trans -0.06%
Short Ratio 3.27
Perf Half Y -10.72%
Book/sh 61.24
P/B 1.77
EPS next Y 7.42%
ROA 4.52%
Short Interest 4.63M
Perf Year -25.14%
Cash/sh 1.91
P/C 56.75
EPS next 5Y 6.91%
ROE 7.79%
52W Range 102.00 - 147.50
Perf YTD -10.92%
Dividend Est. 0.86 (0.79%)
P/FCF 25.02
EPS past 5Y -
ROI 5.53%
52W High -26.51%
Beta 1.02
Dividend TTM 0.96 (0.89%)
Quick Ratio 0.80
Sales past 5Y -1.20%
Gross Margin 62.47%
52W Low 6.28%
ATR (14) 1.95
Dividend Ex-Date Jun 26, 2024
Current Ratio 1.66
EPS Y/Y TTM 116.19%
Oper. Margin 18.19%
RSI (14) 34.31
Volatility 1.65% 1.90%
Employees 18000
Debt/Eq 0.46
Sales Y/Y TTM 4.85%
Profit Margin 12.93%
Recom 2.50
Target Price 135.73
Option/Short Yes / Yes
LT Debt/Eq 0.38
EPS Q/Q -24.33%
Payout 19.66%
Rel Volume 0.92
Prev Close 108.11
Sales Surprise 1.16%
EPS Surprise 3.72%
Sales Q/Q 3.18%
Earnings May 02 BMO
Avg Volume 1.41M
Price 108.40
SMA20 -1.76%
SMA50 -6.66%
SMA200 -8.25%
Trades
Volume 1,082,081
Change 0.27%
Date
Action
Analyst
Rating Change
Price Target Change
May-30-24 Initiated
Goldman
Neutral
$129
May-21-24 Upgrade
Argus
Hold → Buy
$150
Jan-04-24 Downgrade
Evercore ISI
Outperform → In-line
$135 → $125
Oct-20-23 Initiated
ROTH MKM
Neutral
$120
Aug-28-23 Upgrade
BTIG Research
Neutral → Buy
$139
May-03-23 Upgrade
BofA Securities
Underperform → Neutral
Apr-11-23 Upgrade
Evercore ISI
In-line → Outperform
$135 → $148
Mar-31-23 Upgrade
Jefferies
Underperform → Hold
$115 → $130
Mar-29-23 Initiated
UBS
Sell
$112
Mar-10-23 Upgrade
Piper Sandler
Neutral → Overweight
$135 → $145
Jan-09-23 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$125 → $141
Jan-05-23 Upgrade
Raymond James
Mkt Perform → Outperform
$144
Jan-03-23 Downgrade
Evercore ISI
Outperform → In-line
$130
Nov-23-22 Upgrade
Wells Fargo
Underweight → Equal Weight
Oct-18-22 Initiated
Barclays
Underweight
$104
Oct-12-22 Initiated
Jefferies
Underperform
$95
May-27-22 Downgrade
Needham
Buy → Hold
Apr-13-22 Downgrade
Truist
Buy → Hold
$128 → $142
Apr-01-22 Downgrade
Citigroup
Buy → Neutral
$125.15 → $135
Mar-02-22 Resumed
BofA Securities
Underperform
$120
Show Previous Ratings
Jun-20-24 07:30AM
Jun-14-24 09:16AM
07:29AM
Jun-13-24 11:22AM
06:53AM
08:38AM
Loading…
Jun-12-24 08:38AM
06:00AM
Jun-11-24 07:30AM
Jun-04-24 12:14PM
07:30AM
01:38AM
May-30-24 12:21PM
May-29-24 05:02PM
09:40AM
May-23-24 07:10PM
07:55AM
Loading…
May-21-24 07:55AM
May-20-24 08:30AM
06:00AM
May-15-24 08:59AM
03:11AM
May-13-24 09:40AM
07:00AM
May-09-24 07:58AM
May-06-24 07:30AM
May-03-24 12:57PM
11:17AM
11:07AM
09:53AM
09:41AM
08:31AM
08:23AM
Loading…
08:23AM
08:18AM
07:37AM
07:19AM
07:08AM
07:04AM
03:10AM
May-02-24 01:52PM
11:56AM
11:54AM
11:19AM
10:54AM
09:30AM
07:52AM
07:48AM
07:40AM
07:19AM
06:38AM
(Associated Press Finance)
06:30AM
Apr-29-24 09:16AM
Apr-26-24 12:10PM
09:40AM
Apr-25-24 10:01AM
Apr-19-24 10:27AM
Apr-10-24 09:40AM
Apr-04-24 07:30AM
Apr-03-24 07:30AM
Mar-27-24 12:23PM
Mar-13-24 04:30PM
Mar-11-24 08:25AM
Mar-08-24 11:29PM
Feb-29-24 09:40AM
Feb-22-24 07:30AM
05:25AM
Feb-21-24 07:35PM
07:17AM
07:00AM
Feb-18-24 01:26PM
Feb-15-24 06:09AM
Feb-14-24 06:10AM
(Thomson Reuters StreetEvents)
Feb-12-24 09:40AM
07:30AM
07:00AM
Feb-08-24 02:24PM
10:08AM
09:30AM
08:21AM
07:40AM
06:54AM
06:41AM
06:39AM
(Associated Press Finance)
06:30AM
06:09AM
06:09AM
Feb-05-24 09:16AM
Jan-23-24 06:13AM
Jan-22-24 10:42AM
Jan-16-24 07:30AM
Jan-10-24 12:00AM
Jan-05-24 07:30AM
Dec-28-23 10:49AM
Dec-27-23 07:50PM
Dec-19-23 07:30AM
05:00AM
Dec-15-23 07:18AM
(Thomson Reuters StreetEvents)
Dec-14-23 07:00AM
Dec-07-23 11:31AM
Nov-29-23 11:34AM
Nov-24-23 09:50AM
Nov-22-23 09:43PM
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stellato Paul A VP, Controller & CAO Jun 01 '24 Option Exercise 0.00 627 0 1,579 Jun 04 04:20 PM Yi Sang Group President, Asia Pacific May 31 '24 Sale 114.69 12,857 1,474,582 5,322 Jun 04 04:21 PM Winkler Lori SVP and CHRO Apr 01 '24 Option Exercise 0.00 772 0 3,551 Apr 03 04:35 PM Yi Sang Group President, Asia Pacific Mar 07 '24 Option Exercise 91.53 1,705 156,059 19,884 Mar 08 05:03 PM Yi Sang Group President, Asia Pacific Mar 07 '24 Sale 126.86 1,705 216,296 18,179 Mar 08 05:03 PM Upadhyay Suketu Exec. VP, CFO Mar 06 '24 Option Exercise 0.00 4,561 0 22,683 Mar 08 05:05 PM VAN ZUILEN WILFRED Group Pres, EMEA Mar 06 '24 Option Exercise 0.00 2,163 0 7,427 Mar 08 05:05 PM Winkler Lori SVP and CHRO Mar 06 '24 Option Exercise 0.00 1,757 0 3,207 Mar 08 05:05 PM Bezjak Mark President, Americas Mar 06 '24 Option Exercise 0.00 1,622 0 4,753 Mar 08 05:03 PM Ellingson Rachel SVP & Chief Strategy Officer Mar 06 '24 Option Exercise 0.00 1,419 0 7,291 Mar 08 05:03 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 06 '24 Option Exercise 0.00 2,095 0 50,046 Mar 08 05:03 PM Stellato Paul A VP, Controller & CAO Mar 06 '24 Option Exercise 0.00 609 0 1,176 Mar 08 05:04 PM Tornos Ivan President & CEO Mar 06 '24 Option Exercise 0.00 10,270 0 32,395 Mar 08 05:04 PM Yi Sang Group President, Asia Pacific Mar 06 '24 Option Exercise 0.00 2,365 0 18,179 Mar 08 05:03 PM Winkler Lori SVP and CHRO Mar 02 '24 Option Exercise 0.00 186 0 1,496 Mar 05 04:58 PM Yi Sang Group President, Asia Pacific Mar 01 '24 Option Exercise 0.00 2,052 0 15,814 Mar 05 04:59 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Mar 01 '24 Option Exercise 0.00 1,641 0 48,597 Mar 05 05:02 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 25 '24 Option Exercise 0.00 4,580 0 48,725 Feb 27 08:57 PM Tornos Ivan President & CEO Feb 25 '24 Option Exercise 0.00 7,513 0 25,153 Feb 27 08:58 PM Upadhyay Suketu Exec. VP, CFO Feb 25 '24 Option Exercise 0.00 7,043 0 20,213 Feb 27 08:58 PM Bezjak Mark President, Americas Feb 25 '24 Option Exercise 0.00 1,528 0 3,535 Feb 27 08:56 PM Winkler Lori SVP and CHRO Feb 25 '24 Option Exercise 0.00 1,294 0 1,661 Feb 27 08:56 PM Ellingson Rachel SVP & Chief Strategy Officer Feb 25 '24 Option Exercise 0.00 1,762 0 6,460 Feb 27 08:57 PM Yi Sang Group President, Asia Pacific Feb 25 '24 Option Exercise 0.00 5,047 0 13,762 Feb 27 08:55 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 22 '24 Option Exercise 91.53 26,156 2,394,059 70,301 Feb 26 06:02 PM Phipps Chad F Sr. VP/Gen Counsel/Secretary Feb 22 '24 Sale 128.62 26,156 3,364,126 44,145 Feb 26 06:02 PM Jafry Syed A. Director Nov 09 '23 Buy 104.75 2,135 223,641 4,060 Nov 13 04:02 PM Kolli Sreelakshmi Director Aug 30 '23 Buy 120.37 1,000 120,370 1,000 Sep 01 04:01 PM HAGEMANN ROBERT Director Aug 28 '23 Buy 116.48 2,000 232,960 4,000 Aug 30 04:03 PM BEGLEY CHRISTOPHER B Director Aug 28 '23 Buy 117.11 1,000 117,114 3,540 Sep 29 04:05 PM MICHELSON MICHAEL W Director Aug 25 '23 Buy 115.50 1,300 150,150 3,385 Aug 29 06:57 PM BERNARD BETSY J Director Aug 25 '23 Buy 114.84 871 100,023 5,271 Aug 29 06:51 PM HIGGINS ARTHUR J Director Aug 23 '23 Buy 115.61 1,000 115,613 3,400 Aug 25 04:31 PM VAN ZUILEN WILFRED Pres, Europe, M. East & Africa Jul 01 '23 Option Exercise 0.00 2,633 0 5,073 Jul 05 04:07 PM Upadhyay Suketu Exec. VP, CFO Jul 01 '23 Option Exercise 0.00 3,768 0 14,660 Jul 05 04:10 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite